Identification of botanicals with potential therapeutic use against methicillin-resistant Staphylococcus aureus (MRSA) infections

Johanne Gerstel, Tiffany Turner, Guillermo Ruiz, Justin Wise, Ashley Stein, Greg Jones, Tanya Morin, Tony Pinazza, Elena Sukhorukov, Donna Clark, Taelor Steen, Berlin Wright, Jeffrey Langland

Research output: Contribution to journalArticle

Abstract

Staphylococcus aureus is an opportunistic pathogen. Over- and improper-use of pharmaceuticals against S. aureus has led to the development of antibiotic resistance, including methicillin-resistant S. aureus (MRSA). This study examined the efficacy of botanical extracts as an alternative form of treatment to S. aureus and MRSA, including penicillin/methicillin-resistant S. aureus (PenR), and multidrug resistant S. aureus (MDR). Initial screening of botanicals was done via a minimum inhibitory concentration procedure. In addition, a temporal growth curve was performed in order to quantify the growth of the bacteria in the presence of the extracts. Results demonstrated 13 botanicals that had varying activities against S. aureus, PenR, and MDR. These botanicals were separated into mild, moderate, and highly efficacious based on the concentration needed to inhibit bacterial growth. These results propose a comparison of botanical-derived antimicrobial extracts that may be utilized against S. aureus and different antibiotic resistant strains of MRSA.

Original languageEnglish (US)
JournalPhytotherapy Research
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Therapeutic Uses
Methicillin-Resistant Staphylococcus aureus
Methicillin Resistance
Growth
Infection
Microbial Sensitivity Tests
Microbial Drug Resistance
Penicillins
Staphylococcus aureus
Anti-Bacterial Agents
Bacteria
Pharmaceutical Preparations

Keywords

  • antibiotic resistance
  • botanical
  • MRSA
  • Staphylococcus aureus
  • tincture

ASJC Scopus subject areas

  • Pharmacology

Cite this

Identification of botanicals with potential therapeutic use against methicillin-resistant Staphylococcus aureus (MRSA) infections. / Gerstel, Johanne; Turner, Tiffany; Ruiz, Guillermo; Wise, Justin; Stein, Ashley; Jones, Greg; Morin, Tanya; Pinazza, Tony; Sukhorukov, Elena; Clark, Donna; Steen, Taelor; Wright, Berlin; Langland, Jeffrey.

In: Phytotherapy Research, 01.01.2018.

Research output: Contribution to journalArticle

Gerstel, J, Turner, T, Ruiz, G, Wise, J, Stein, A, Jones, G, Morin, T, Pinazza, T, Sukhorukov, E, Clark, D, Steen, T, Wright, B & Langland, J 2018, 'Identification of botanicals with potential therapeutic use against methicillin-resistant Staphylococcus aureus (MRSA) infections', Phytotherapy Research. https://doi.org/10.1002/ptr.6198
Gerstel, Johanne ; Turner, Tiffany ; Ruiz, Guillermo ; Wise, Justin ; Stein, Ashley ; Jones, Greg ; Morin, Tanya ; Pinazza, Tony ; Sukhorukov, Elena ; Clark, Donna ; Steen, Taelor ; Wright, Berlin ; Langland, Jeffrey. / Identification of botanicals with potential therapeutic use against methicillin-resistant Staphylococcus aureus (MRSA) infections. In: Phytotherapy Research. 2018.
@article{a8fa2d5e1ed04d3188de69e3a1568874,
title = "Identification of botanicals with potential therapeutic use against methicillin-resistant Staphylococcus aureus (MRSA) infections",
abstract = "Staphylococcus aureus is an opportunistic pathogen. Over- and improper-use of pharmaceuticals against S. aureus has led to the development of antibiotic resistance, including methicillin-resistant S. aureus (MRSA). This study examined the efficacy of botanical extracts as an alternative form of treatment to S. aureus and MRSA, including penicillin/methicillin-resistant S. aureus (PenR), and multidrug resistant S. aureus (MDR). Initial screening of botanicals was done via a minimum inhibitory concentration procedure. In addition, a temporal growth curve was performed in order to quantify the growth of the bacteria in the presence of the extracts. Results demonstrated 13 botanicals that had varying activities against S. aureus, PenR, and MDR. These botanicals were separated into mild, moderate, and highly efficacious based on the concentration needed to inhibit bacterial growth. These results propose a comparison of botanical-derived antimicrobial extracts that may be utilized against S. aureus and different antibiotic resistant strains of MRSA.",
keywords = "antibiotic resistance, botanical, MRSA, Staphylococcus aureus, tincture",
author = "Johanne Gerstel and Tiffany Turner and Guillermo Ruiz and Justin Wise and Ashley Stein and Greg Jones and Tanya Morin and Tony Pinazza and Elena Sukhorukov and Donna Clark and Taelor Steen and Berlin Wright and Jeffrey Langland",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/ptr.6198",
language = "English (US)",
journal = "Phytotherapy Research",
issn = "0951-418X",
publisher = "John Wiley and Sons Ltd",

}

TY - JOUR

T1 - Identification of botanicals with potential therapeutic use against methicillin-resistant Staphylococcus aureus (MRSA) infections

AU - Gerstel, Johanne

AU - Turner, Tiffany

AU - Ruiz, Guillermo

AU - Wise, Justin

AU - Stein, Ashley

AU - Jones, Greg

AU - Morin, Tanya

AU - Pinazza, Tony

AU - Sukhorukov, Elena

AU - Clark, Donna

AU - Steen, Taelor

AU - Wright, Berlin

AU - Langland, Jeffrey

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Staphylococcus aureus is an opportunistic pathogen. Over- and improper-use of pharmaceuticals against S. aureus has led to the development of antibiotic resistance, including methicillin-resistant S. aureus (MRSA). This study examined the efficacy of botanical extracts as an alternative form of treatment to S. aureus and MRSA, including penicillin/methicillin-resistant S. aureus (PenR), and multidrug resistant S. aureus (MDR). Initial screening of botanicals was done via a minimum inhibitory concentration procedure. In addition, a temporal growth curve was performed in order to quantify the growth of the bacteria in the presence of the extracts. Results demonstrated 13 botanicals that had varying activities against S. aureus, PenR, and MDR. These botanicals were separated into mild, moderate, and highly efficacious based on the concentration needed to inhibit bacterial growth. These results propose a comparison of botanical-derived antimicrobial extracts that may be utilized against S. aureus and different antibiotic resistant strains of MRSA.

AB - Staphylococcus aureus is an opportunistic pathogen. Over- and improper-use of pharmaceuticals against S. aureus has led to the development of antibiotic resistance, including methicillin-resistant S. aureus (MRSA). This study examined the efficacy of botanical extracts as an alternative form of treatment to S. aureus and MRSA, including penicillin/methicillin-resistant S. aureus (PenR), and multidrug resistant S. aureus (MDR). Initial screening of botanicals was done via a minimum inhibitory concentration procedure. In addition, a temporal growth curve was performed in order to quantify the growth of the bacteria in the presence of the extracts. Results demonstrated 13 botanicals that had varying activities against S. aureus, PenR, and MDR. These botanicals were separated into mild, moderate, and highly efficacious based on the concentration needed to inhibit bacterial growth. These results propose a comparison of botanical-derived antimicrobial extracts that may be utilized against S. aureus and different antibiotic resistant strains of MRSA.

KW - antibiotic resistance

KW - botanical

KW - MRSA

KW - Staphylococcus aureus

KW - tincture

UR - http://www.scopus.com/inward/record.url?scp=85053716599&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053716599&partnerID=8YFLogxK

U2 - 10.1002/ptr.6198

DO - 10.1002/ptr.6198

M3 - Article

JO - Phytotherapy Research

JF - Phytotherapy Research

SN - 0951-418X

ER -